Literature DB >> 20071325

Resumption of sinus rhythm in patients with heart failure and permanent atrial fibrillation undergoing cardiac resynchronization therapy: a longitudinal observational study.

Maurizio Gasparini1, Jonathan S Steinberg, Aysha Arshad, François Regoli, Paola Galimberti, Arnaud Rosier, Jean Claude Daubert, Catherine Klersy, Ganesh Kamath, Christophe Leclercq.   

Abstract

AIMS: To investigate the temporal patterns, predictors, and prognostic impact of spontaneous sinus rhythm resumption (SRR) of heart failure (HF) patients with permanent atrial fibrillation (AF) treated with cardiac resynchronization therapy (CRT). METHODS AND
RESULTS: This multicentre, retrospective, longitudinal study analysed 330 consecutive HF patients with permanent AF treated with a CRT device (mean age 70 +/- 9 years, male 83%, ischaemic aetiology 44%, NYHA class III-IV 93%, mean QRS duration 167 +/- 40 ms, and mean ejection fraction 26 +/- 7%). Clinical, echocardiographic, and outcome data were collected during follow-up. Thirty-four patients experienced SRR after CRT (10.3%) at a median 4-month follow-up. The strongest independent predictors were end-diastolic diameter (EDD) [hazard ratios (HR) 4.03, 95% confidence intervals (95% CI) 1.43-11.36, P = 0.008], post-CRT QRS <or=150 ms (HR 2.63, 95% CI 1.02-6.67, P = 0.05), left atrium (LA) diameter <or=50 mm (HR 4.76, 95% CI 1.72-11.82, P = 0.002), and atrioventricular junction (AVJ) ablation (HR 4.27, 95% CI 1.54-11.84, P = 0.02). The coexistence of three predictors vs. zero to two predictors increased by 3.5-fold the likelihood of SRR; while the presence of all four factors improves the probability by a factor of 5.7-fold. Sinus rhythm resumption was associated with a significantly better long-term survival (log rank P = 0.03).
CONCLUSION: One in every 10 HF patients with permanent AF may experience SRR after CRT. Baseline EDD <or=65 mm, CRT-paced QRS <or=150 ms, LA <or=50 mm, and AVJ ablation appear to be predictive of this phenomenon.

Entities:  

Mesh:

Year:  2010        PMID: 20071325     DOI: 10.1093/eurheartj/ehp572

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  18 in total

1.  Nonpharmacological Treatment of Atrial Fibrillation: What Is the Role of Device Therapy?

Authors:  Lucie Riedlbauchová; Václav Durdil; Jakub Honěk; Josef Veselka
Journal:  Int J Angiol       Date:  2020-04-28

Review 2.  The changing landscape of cardiac pacing.

Authors:  S Serge Barold; Carsten W Israel
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2015-03

Review 3.  Cardiac Resynchronization Therapy and Atrial Fibrillation.

Authors:  Ganesh S Kamath; Jonathan S Steinberg
Journal:  J Atr Fibrillation       Date:  2011-09-30

Review 4.  Treatment Considerations for a Dual Epidemic of Atrial Fibrillation and Heart Failure.

Authors:  Parikshit S Sharma; David J Callans
Journal:  J Atr Fibrillation       Date:  2013-08-31

Review 5.  Enhancing Cardiac Resynchronization Therapy for Patients with Atrial Fibrillation: The Role of AV Node Ablation.

Authors:  Jeff M Berry; Jose AJoglar
Journal:  J Atr Fibrillation       Date:  2012-04-14

Review 6.  Management of Patients with Atrial Fibrillation: Focus on Treatment Options.

Authors:  Pawel Matusik; Jacek Lelakowski; Barbara Malecka; Jacek Bednarek; Remigiusz Noworolski
Journal:  J Atr Fibrillation       Date:  2016-10-31

Review 7.  Is cardiac resynchronization therapy an antiarrhythmic therapy for atrial fibrillation? A systematic review and meta-analysis.

Authors:  Paul L Hess; Kevin P Jackson; Vic Hasselblad; Sana M Al-Khatib
Journal:  Curr Cardiol Rep       Date:  2013-02       Impact factor: 2.931

8.  Feasibility and efficacy of electrical cardioversion after cardiac resynchronization implantation in patients with permanent atrial fibrillation.

Authors:  Pietro Turco; Antonio D'Onofrio; Giuseppe Stabile; Francesco Solimene; Vincenzo La Rocca; Filippo Vecchione; Assunta Iuliano; Natale Marrazzo; Stefano De Vivo; Ciro Cavallaro; Valter Bianchi; Alessia Agresta; Carmine Ciardiello; Antonio De Simone
Journal:  J Interv Card Electrophysiol       Date:  2012-08-14       Impact factor: 1.900

9.  Combined management of atrial fibrillation and heart failure: case studies.

Authors:  Frederik H Verbrugge; Wilfried Mullens
Journal:  Heart Fail Rev       Date:  2014-05       Impact factor: 4.214

10.  Comparative Effectiveness of Cardiac Resynchronization Therapy Among Patients With Heart Failure and Atrial Fibrillation: Findings From the National Cardiovascular Data Registry's Implantable Cardioverter-Defibrillator Registry.

Authors:  Prateeti Khazanie; Melissa A Greiner; Sana M Al-Khatib; Jonathan P Piccini; Mintu P Turakhia; Paul D Varosy; Frederick A Masoudi; Lesley H Curtis; Adrian F Hernandez
Journal:  Circ Heart Fail       Date:  2016-06       Impact factor: 8.790

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.